** Australian healthcare stocks .AXHJ fall as much as 1.4% - biggest intraday pct decline since June 23
** U.S. President Donald Trump says he will announce tariffs on pharmaceutical imports potentially at the end of July, starting with a 'low tariff' to give companies time to move their manufacturing units to the U.S. before imposing a 'very high tariff' in a year or so
** Australian pharmaceutical firms benefit significantly from U.S. sales
** Sector giant CSL CSL.AX falls 1.8% while Telix Pharmaceuticals TLX.AX down 0.7%
** Sub-index down 5.8% YTD vs 4.9% in broader benchmark .AXJO
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.kumar@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。